349 related articles for article (PubMed ID: 2059078)
1. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
Arber N; Klein T; Meiner Z; Pras E; Weinberger A
Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
[TBL] [Abstract][Full Text] [Related]
2. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
Cohen R; Metzger S; Nahir M; Chajek-Shaul T
Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
[TBL] [Abstract][Full Text] [Related]
3. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
4. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
[TBL] [Abstract][Full Text] [Related]
5. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
[TBL] [Abstract][Full Text] [Related]
6. Behçet's syndrome in Iranian Azari people.
Shahneh FZ; Babaloo Z; Baradaran B; Hamzavi F; Bayazi B; Bandehagh A
Pak J Biol Sci; 2012 Nov; 15(21):1045-7. PubMed ID: 24163948
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behçet's disease pathogenesis.
Gur M; Golcuk M; Gul A; Erman B
Chem Biol Drug Des; 2020 Jul; 96(1):644-658. PubMed ID: 32691964
[TBL] [Abstract][Full Text] [Related]
8. Familial Behçet's disease.
Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
[TBL] [Abstract][Full Text] [Related]
9. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.
Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanović S; Jung G; Rammensee HG
Int Immunol; 1995 Feb; 7(2):223-8. PubMed ID: 7734418
[TBL] [Abstract][Full Text] [Related]
10. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
[TBL] [Abstract][Full Text] [Related]
11. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
[TBL] [Abstract][Full Text] [Related]
12. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
[TBL] [Abstract][Full Text] [Related]
13. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
14. HLA-C genotyping of patient with Behçet's disease in the Japanese population.
Mizuki N; Ohno S; Ando H; Kimura M; Ishihara M; Miyata S; Nakamura S; Mizuki N; Inoko H
Hum Immunol; 1996 Sep; 50(1):47-53. PubMed ID: 8872174
[TBL] [Abstract][Full Text] [Related]
15. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Palimeris GD; Kaklamani E; Ito D; Ohno S; Inoko H
Tissue Antigens; 2002 Feb; 59(2):118-21. PubMed ID: 12028538
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
17. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
[TBL] [Abstract][Full Text] [Related]
18. Close association of HLA-Bw51 with Behçet's disease.
Ohno S; Ohguchi M; Hirose S; Matsuda H; Wakisaka A; Aizawa M
Arch Ophthalmol; 1982 Sep; 100(9):1455-8. PubMed ID: 6956266
[TBL] [Abstract][Full Text] [Related]
19. A study of familial occurrence of Behçet's disease with and without ocular lesions.
Nishiyama M; Nakae K; Umehara T
Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
[TBL] [Abstract][Full Text] [Related]
20. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
